Objective Aceruloplasminemia is an iron metabolic disorder caused by mutations in the ceruloplasmin gene. It is characterized by progressive neurodegeneration in association with iron accumulation. Excess iron functions as a potent catalyst of biologic oxidation. Previously we showed that an increased iron concentration is associated with the products of lipid peroxidation in the serum, cerebrospinal fluid, and brain tissues. To clarify the free radical-mediated tissue injury caused by intracellular iron accumulation through mitochondrial dysfunction. Patients and MethodsWehave measure brain oxygen and glucose metabolisms using positron emission tomography (PET) and examined brains at autopsy for iron contents and activities of the mitochondrial respiratory chain in two affected patients whohad different truncation mutations of the ceruloplasmin gene. Results PET showed a marked decrease in glucose and oxygen consumption in the entire brain of aceruloplasminemia patients, with a preponderance of metabolic reduction in basal ganglia. Enzymeactivities in the mitochondrial respiratory chain of the basal ganglia were reduced to approximately 45% and 42%respectively for complexes I and IV. Aninverse relationship was shown between the amounts of iron accumulated and the levels of mitochondrial enzymeactivities in all the brain regions examined. Conclusion Iron-mediated free radicals maycontribute to the impairment of mitochondrial energy metabolism in aceruloplasminemia. (Internal Medicine 41: 186-190, 2002) 
Introduction
Ceruloplasmin is expressed in the central nervous system as well as in visceral organs and functions in brain iron metabolism. It plays an essential role for neuronal survival in the central nervous system (1) . Aceruloplasminemia, an autosomal recessive disorder that affects iron metabolism, is caused by mutations of the ceruloplasmin gene. Clinically, the disease consists of the triad of neurologic disease, retinal degeneration, and diabetes mellitus (DM). The neurological symptoms, which include involuntary movements, ataxia, and dementia, reflect the sites of iron deposition. The actual pathogenesis of aceruloplasminemia is not yet clear, but iron-mediated, freeradical stress is speculated to contribute to neuronal cell death. Weearlier reported a marked increase in lipid peroxidation in the plasma (2) , CSF (3), and brain (4) of patients with aceruloplasminemia. Wehypothesized that oxidative energy metabolism is impaired in the aceruloplasminemia brain and used positron emission tomography (PET) to measure brain oxygen (CMRO2)and glucose (CMFXjIc) metabolisms and examined activities of the mitochondrial respiratory chain in the brain. thalamus, and dentate nucleus on both Tl-and T2-weighted MRimages were indicative of iron accumulation. There was no cerebral infarction or hemorrhage (Fig. 1) . Moreover, there was mutation of a 5-base insertion at amino acid 410, resulting in a frame-shift mutation and premature termination. She died from pancreatic cancer at age 66. Patient 2 was a 60-year-old man who had had DMand insulin therapy for 25 years and scanning speech and forgetfulness from age 56 (6) . He had retinal degeneration and bilateral hearing disturbance. Facial grimacing and choreic involuntary movementsof the upper extremities occurred during speech or voluntary movement of the extremities. Both his trunk and extremities showedcerebellar ataxia, and his gait was ataxic. His full-scale IQ was 68; verbal IQ, 70 and performance IQ, 62 on the WAIS. MMSEscore was 15. His laboratory findings were more severe than those of patient 1. Serum ceruloplasmin was absent because of mutation of the ceruloplasmin gene, the insertion of adenine in exon 3 producing a premature stop codon. He had had liver dysfunction from age 57 and died from cardiac failure at age 60.
Patients and Methods

Pa tien ts
Methods
Brains were obtained at autopsy within 6 hours of death from the two patients with aceruloplasminemia and from four control subjects, mean age 62 years (two men and two women, 60-65 years old). The control subjects had arteriosclerosis and asymptomatic cerebral lacunae infarctions, and the cause of their deaths was acute myocardial infarction. The basal ganglia, thalamus, cerebral and cerebellar cortices were separated from the brain less than 1 hour after autopsy. Samples of each brain area were cut immediately into small sections that then were frozen at -70°C for biochemical examination. PET PET was performed with a high resolution scanner (SHR2400, Hamamatsu Photonics K.K., Japan) that had five detector rings, yielding 9 slice images simultaneously (7). The scanner's spatial resolution was 2.7 mmhorizontally and 5.5 mmaxially. A thermoplastic face maskdesigned for radiosurgery was used for head fixation during the following transmission and emission scans. A 20-min transmission scan for attenuation correction was made with a 68Ge/68Gasource. The 15O steady-state inhalation method (8) that consecutively uses 15O-CO2 (for cerebral blood flow, CBF) and 15O-O2 (for the oxygen extraction fraction, OEF) was used followed by short inhalation of I5O-COfor correction of the intravascular tracer (cerebral blood volume, CBV) (9, 10). The gases delivered at tracer doses (15O-CO2; 200 MBq/min, 15O-O2; 400 MBq/min, 15O-CO; 1,500 MBq/min) in air were inhaled through a tightly fitting plastic oxygen face mask placed over the patient's face. Emission data were acquired for three 5-minute periods. During each of the acquisition periods, two or three pairs of arterial blood samples were collected (1 1). Arterial blood gas, oxygen saturation (SaO2), arterial hemoglobin (Hb) and hematocrit value measurements allowed us to calculate the arterial oxygen content (CaO2) by the formula CaO2=1.39xSaO2xHb. By means of the steady-state technique (8) , functional images for CBF, CBV-corrected OEFand CBVwere reconstructed pixel by pixel (1.45x1.45x8 mm). A pixel-based CMRO2image finally was created from the equation CMR02=CBFx0EFxCa02. After completion of the 15O-gas study, 185 MBqof 18F-fluorodeoxyglucose was injected intravenously, and periodic arterial blood sampling was begun simultaneously for the quantitative measurement of glucose metabolism ( 1 2). CMRGlcwas measured by an autoradiographic method (13).
Mitochondrial enzyme assay
Approximately 200 mgof the brain tissue was taken from each patient and 4 controls. Each brain sample was removed from liquid nitrogen storage, weighed, and homogenized in a glass homogenizer in 9 volumes of ice-cold medium (32 mM sucrose, 1 mMEDTA, 10 mMTris, pH 7.4). After three cycles of freezing and thawing, mitochondrial enzymeswere assayed. NADH-ubiquinoneoxidoreductase (complex I), succinate cytochrome c reductase (complex II+III) and cytochrome c oxidase (complex IV) were assayed by the method of Bowling et al (14) .
Iron concentrations
Brain tissue was dried in a microwave digestion unit (MLS-1200 MEGA,Milestone General, Kawasaki) until a constant weight (10-15 mg) was obtained. The dried powder was weighed, and 0.7 ml samples of the ashed solutions were prepared with 0. 1 N HC1. Sample solutions were analyzed directly in an atomic absorption spectrophotometer (Hitachi Z-6100, Tokyo) as described previously (15) . Data was calculated on a dry weight basis because tissue density was not uniform in all the brain areas. CMRO2 in the basal ganglia and thalamus as well as cerebral and cerebellar cortices of the aceruloplasminemia patients (Fig.  2) . The levels of CMGlcand CMRO2 in the basal ganglia and thalamus of the patient were markedly decreased about 58% of the control values, and those in the cerebral and cerebellar cortices were reduced to 65%of the control values (Table 1) . CBFvalues did not differ from the control values. Reductions in glucose and oxygen metabolism along with preservation of perfusion were found diffusely throughout the brain. Decreased CMGlcand CMRO2 values were greater in patient 2 than in patient 1.
Mitochondria! enzyme assay Enzymeactivities in the control and aceruloplasminemia brains are shown in Table 2 . Highly significant decreases in complex I activities in the brains were found for the aceruloplasminemiapatients, whereas complexII+III activities were within the control range. ComplexI activities in the basal ganglia and thalamus of our patients were decreased less than 45%of the control values. Complex IV activities also were significantly reduced to about 42% (basal ganglia) and 68% (cerebral cortex) of the control values.
The distribution in order of iron level in both the aceruloplasminemia and control brains was basal ganglia > thalamus > cerebral cortex, cerebellar cortex. Iron contents weremarkedly elevated in the basal ganglia of patients with aceruloplasminemia ( Table 3 ). The amounts of iron accumulated in all the regions examined were greater in patient 2 than in patient 1. Aceruloplas-minemia Normal controls (5 men and 4 women, mean age±SD: 60.2±12.3 year). CBF: cerebral blood flow (ml/100 g/minute), CMRO2: cerebral metabolic rate of oxygen (fimol/100 g/minute), CMRGlc: cerebral metabolic rate of glucose (|imol/100 g/minute). Significance was determined by the Mann-Whitney U-test (*p<0.05).
Dis cussion
Almost all the energy used by the brain's cells is supplied by glucose metabolized by the mitochondrial respiratory chain and oxidative phosphorylation system. PET studies showed (16) . Although the present case report did not allow us to conclude about brain pathophysiology of patients with aceruloplasminemia, we speculated that diffuse brain energy hypometabolism is secondary to mitochondrial deficit. This speculation was partly supported by the mitochondrial enzyme assay showing significantly deficient mitochondrial activities in complexes I and IV in the aceruloplasminemia brains. Defects in oxidative phosphorylation and oxidative damagemay be important in a variety of neurodegenerative diseases, including Parkinson' s disease, Huntington' s disease, Friedrich's ataxia, and Alzheimer's disease (17, 18) . The progressive course and age-related increase in the incidences of these disorders may be due to the interaction between oxidative damageand defects in the mitochondrial respiratory chain. Studies with isolated submitochondrial particles showed that complexes I and IV are the respiratory chain component most sensitive to oxidative damage (19, 20) . Weelsewhere reported a marked increase in lipid peroxidation in the brain of patients with aceruloplasminemia (4). Mitochondrial complexes are membrane-boundarid sensitive to the lipid environment.
Change in the lipid environment, such as increased lipid peroxidation, could result in inhibition of the respiratory chain function (21) . The reduction of CMRGlcin the basal ganglia was more remarkable than in the cerebral and cerebellar cortices in patients with aceruloplasminemia. The iron contents were higher in the basal ganglia than in the cerebral and cerebellar cortices. An inverse relationship was shown between the amounts of iron accumulated and the levels of mitochondrial enzymeactivities in all of the brain regions examined. The amounts of iron accumulated in our patient 2, whoshowed progressive involuntary movement,ataxia, and dementia, were greater than those in patient 1, whosesymptomswere mild. Central nervous system damage caused by excess iron through its ability to donate an electron and to promote oxygen free radical formation reflects the site and iron content deposited, as well as the process of iron deposition in the brain. Mitochondrial energy metabolism in the aceruloplasminemia brain may be vulnerable to iron-mediated free radical damage and may be a part of the pathogenesis. 
